Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer

Gynecologic Oncology

Volumn 64, Issue 1, 1997, Pages 141-146

  Vuento, Maarit H ^a,d   Stenman, Ulf Håkan ^b   Pirhonen, Jouko P ^a   Mäkinen, Juha I ^a   Laippala, Pekka J ^c   Salmi, Tuula A ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ARTICLE; CANCER SURVIVAL; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; FEMALE; HUMAN; NORMAL HUMAN; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSVAGINAL ECHOGRAPHY;

EID: 17744410910     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.4545     Document Type: Article

References (31)

1. 1. Kabawat, S. E., Bast, R. C., Jr., Bhan, A. K., Welch, W. R., Knapp, R. C., and Colvin, R. B. Tissue distribution of a coelomic epithelium-related antigen recognized by the monoclonal antibody OC 125, Int. J. Gynecol. Pathol. 2, 275-285 (1983).
2. 2. Niloff, J. M., Klug, T. L., Schaetzl, E., Zurawski, V. R., Knapp, R. C., and Bast, R. C., Jr. Elevation of serum CA-125 in carcinomas of the fallopian tube, endometrium, and endocervix, Am. J. Obstet. Gynecol. 148, 1057-1058 (1984).
3. 3. Tokunaga, T., Miyazaki, K., Matsuyama, S., and Okamura, H. Serial measurement of CA 125 in patients with primary carcinoma of the fallopian tube, Gynecol. Oncol. 36, 335-337 (1990).
4. 4. Bast, R. C., Jr., Klug, T. L., St. John, E., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L., Zurawski, V. R., and Knapp, R. C. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer, N. Engl. J. Med. 309, 883-887 (1983).
5. 5. Haglund, C. Tumour markers in pancreatic cancer, Dissertation, University of Helsinki, Helsinki, (1987).
6. 6. Kawahara, M., Teraski, P. I., Chia, D., Johnson, C., Hermes, M., and Tokita, K. Use of four monoclonal antibodies to detect tumor markers, Cancer 58, 2008-2012 (1986).
7. 7. Halila, H., Stenman, U-H., and Seppälä, M. Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy, Cancer 57, 1327-1329 (1986).
8. 8. Barbieri, R. L., Niloff, J. M., Bast, R. C., Jr., Schaetzl, E., Kistner, R. W., and Knapp, R. C. Elevated serum concentrations of CA 125 in patients with advanced endometriosis, Fertil. Steril. 45, 630-634 (1986).
9. 9. Pittaway, D. E., and Payez, J. A. Serum CA 125 antigen levels increase during menses, Am. J. Obstet. Gynecol. 156, 75-76 (1987).
10. 10. Zurawski, V. R., Jr., Broderick, S., Pickens, P., Knapp, R., and Bast, R. Serum CA 125 levels in a group of non-hospitalized women: Relevance for early detection of ovarian cancer, Obstet. Gynecol. 69, 606-611 (1987).
11. 11. Einhorn, N., Sjövall, K., Schoenfeld, D., Eklund, G., Knapp, R., Bast, R. C. Jr., et al. Early detection of ovarian cancer using the CA 125 radioimmunoassay (RIA), Proc. Am. Soc. Clin. Oncol. 9, 157 (1990).
12. 12. Zurawski, V. R., Jr., Sjovall, K., Schoenfeld, D. A., Broderick, S. F., Hall, P., Bast, R. C. Jr., Eklund, G., Mattson, B., Connor, R. J., Prorok, P. C., Knapp, R. C., and Einhorn, N. Prospective evaluation of serum CA 125 levels in a normal population, phase I: The specificities of single and serial determinations in testing for ovarian cancer, Gynecol. Oncol. 36, 299-305 (1990).
13. 13. van Kamp, G. J., Verstraeten, A. A., and Kenemans, P. Discordant serum CA 125 values in commercial immunoassays, Eur. J. Obstet. Gynecol. Reprod. Biol. 49, 99-103 (1993).
14. 14. Kenemans, P., Bon, G. G., Kessler, A. C., Verstraeten, A. A., and van Kamp, G. J. Multicenter technical and clinical evaluation of a fully automated enzyme immunoassay for CA 125, Clin. Chem. 38, 1466-1471 (1992).
15. 15. O'Brien, T. J., Raymond, L. M., Bannon, G. A., Ford, D. H., Hardardottir, H., Miller, F. C., and Quirk, J. G., Jr. New monoclonal antibodies identify the glycoprotein carrying the CA 125 epitope, Am. J. Obstet. Gynecol. 165, 1857-1864 (1991).
16. 16. Kenemans, P., van Kamp, G. J., Oehr, P., and Verstraeten, R. A. Heterologous double-determinant immunoradiometric assay CA 125 II: Reliable second-generation immunoassay for determining CA 125 in serum, Clin. Chem. 39(12), 2509-2513 (1993).
17. 17. Kenemans, P., Yedema, C. A., Bon, G. G., and von Mensdorff-Pouilly, S. CA 125 in gynecological pathology - A review, Eur. J. Obstet. Gynecol. Reprod. Biol. 49, 115-124 (1993).
18. 18. Duk, J. M., Aalders, J. G., Fleuren, G. J., and de Bruijn, H. W. A. CA 125: A useful marker in endometrial carcinoma, Am. J. Obstet. Gynecol. 155, 1097-1102 (1986).
19. 19. Jacobs, I., Bridges, J., Reynolds, C., Stabile, I., Kemsley, P., Grudzinskas, J., and Oram, D. Multimodal approach to screening for ovarian cancer, Lancet 1, 268-271 (1988).
20. 20. Jacobs, I., Prys Davies, A., Bridges, J., Stabile, I., Fay, T., Lower, A., Grudzinskas, J. G., and Oram, D. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography, Br. Med. J. 306, 1030-1034 (1993).
21. 21. Graver, S., Quinn, M. A., Weideman, P., Koh, H., Robinson, H. P., Rome, R.,and Cauchi, M. Screening for ovarian cancer using serum CA 125 and vaginal examination: report on 2550 females, Int. J. Gynecol. Cancer 5, 291-295 (1995).
22. 22. Bast, R. C., Jr., Siegal, F. P., Runowicz, C., Klug, T. L., Zurawski, V. R., Jr., Schonholz, D., Cohen, C. J., and Knapp, R. C. Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma, Gynecol. Oncol. 22: 115-120 (1985).
23. 23. Zurawski, V. R. Jr., Knapp, R. C., Einhorn, N., Kenemans, P., Mortel, R., Ohmi, K., Bast, R. C. Jr., Ritts, R. E., Jr., and Malkasian, G. A. An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma, Gynecol. Oncol. 30, 7-14 (1988).
24. 24. Vuento, M. H., Pirhonen, J. P., Mäkinen, J. I., Laippala, P. J., Grönroos, M., and Salmi, T. A. Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound, Cancer 76, 1214-1218 (1995).
25. 25. Teppo, L., Pukkala, E., and Lehtonen, M. Data quality and quality control of a population-based cancer registry. Experience in Finland, Acta Oncol. 33(4), 365-369 (1994).
26. 26. Finnish Cancer Registry. Incidence, mortality and prevalence by region, in Cancer in Finland in 1954-2008. Finnish Foundation for Cancer Research, Cancer Society of Finland Publication No. 42. Helsinki (1989).
27. 27. Boring, C., Squires, T.,and Tong, T. Cancer statistics 1992, CA Cancer J. Clin. 42, 19-38 (1992).
28. 28. Silverberg, E., and Lubera, J. Cancer statistics, Cancer J. Clin. 39, 3-10 (1987).
29. 29. Christopherson, W. M., Mendez, W. M., Parker, J. E., Lundin, F. E., and Ahuja, E. M. Carcinoma of the endometrium: A study of changing rates over a 15-year period, Cancer 27, 1005-1008 (1971).
30. 30. Granberg, S., Wikland, M., and Friberg, L-G. Tumor marker CA 125 level and ovarian volume at different cycle day periods and in postmenopause, Int. J. Gynecol. Obstet. 33, 149-152 (1990).
31. 31. Westhoff, C., Gollub, E., Patel, J., Rivera, H., and Bast, R., Jr. Ca 125 levels in menopausal women, Obstet. Gynecol. 76, 428-431 (1990).